MARKET

CASI

CASI

Casi Pharmaceuticals Inc
NASDAQ
2.630
+0.010
+0.38%
After Hours: 2.570 -0.06 -2.28% 16:16 01/21 EST
OPEN
2.738
PREV CLOSE
2.620
HIGH
2.860
LOW
2.560
VOLUME
22.72K
TURNOVER
--
52 WEEK HIGH
8.19
52 WEEK LOW
2.050
MARKET CAP
40.75M
P/E (TTM)
-1.1792
1D
5D
1M
3M
1Y
5Y
1D
CASI Pharmaceuticals Faces Asset Freezing Amid Arbitration Dispute
TipRanks · 19h ago
Weekly Report: what happened at CASI last week (0113-0117)?
Weekly Report · 1d ago
Weekly Report: what happened at CASI last week (0106-0110)?
Weekly Report · 01/13 10:56
Casi Pharmaceuticals announces first patient dosed in Phase 1/2 trial of CID-103
TipRanks · 01/06 13:30
Weekly Report: what happened at CASI last week (1230-0103)?
Weekly Report · 01/06 11:03
Weekly Report: what happened at CASI last week (1223-1227)?
Weekly Report · 12/30/2024 10:58
BRIEF-CASI Pharmaceuticals Announces Clinical Hold Of CID-103
Reuters · 12/26/2024 15:41
BUZZ-Casi Pharmaceuticals falls after FDA puts experimental antibody drug on hold
Reuters · 12/26/2024 14:23
More
About CASI
CASI Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing, and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. Its commercial product, EVOMELA, is an intravenous formulation of melphalan commercialized by Acrotech in the multiple myeloma treatment setting in the United States. Its pipeline products include CNCT19 (CD19 CAR-T), BI-1206 (anti- FcYRIIB antibody), CB-5339 (VCP/p97 inhibitor), CID-103 (Anti-CD38 Mab), Thiotepa, and Octreotide LAI. The Company’s Food and Drug Administration (FDA)-approved generic products for the China market include Entecavir tablets, Tenofovir disoproxil fumarate (TDF) tablets, Cilostazol tablets-50mg, Cilostazol tablets-100mg, Ondansetron HCL tablets, and Tizanidine tablets.

Webull offers CASI Pharmaceuticals Inc stock information, including NASDAQ: CASI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CASI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CASI stock methods without spending real money on the virtual paper trading platform.